Surface-Modified Carboxylated Cellulose Nanofiber Hydrogels for Prolonged Release of Polyhexamethylene Biguanide Hydrochloride (PHMB) for Antimicrobial Applications
Polymers · 28.08.2023 · 15 (17) · 3572
DOI: 10.3390/polym15173572 ↗Kurz gefasst
Fachartikel in der Zeitschrift Polymers, online erschienen am 28.08.2023. Verfasst von Pichapar O-Chongpian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Council of Thailand, Chiang Mai University.
Abstract (Originalsprache)
The surface modification of cellulose nanofibers (CNFs) using a 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO)/sodium bromide (NaBr)/sodium hypochlorite (NaClO) system was successful in improving their hydrophilicity. Following that, we fabricated hydrogels containing carboxylated cellulose nanofibers (c-CNFs) and loaded them with polyhexamethylene biguanide (PHMB) using a physical crosslinking method, aiming for efficient antimicrobial uses. The morphological and physicochemical properties of all hydrogel formulations were characterized, and the results revealed that the 7% c-CNFs-2 h loaded with PHMB formulation exhibited desirable characteristics such as regular shape, high porosity, good mechanical properties, suitable gel content, and a good maximum swelling degree. The successful integration of PHMB into the c-CNF matrix was confirmed by FTIR analysis. Furthermore, the 7% c-CNFs-2 h loaded with the PHMB formulation demonstrated PHMB contents exceeding 80% and exhibited a prolonged drug release pattern for up to 3 days. Moreover, this formulation displayed antibacterial activity against S. aureus and P. aeruginosa. In conclusion, the novel approach of c-CNF hydrogels loaded with PHMB through physical crosslinking shows promise as a potential system for prolonged drug release in topical drug delivery while also exhibiting excellent antibacterial activity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.
- Division of Packaging Technology, Faculty of Agro-Industry, Chiang Mai University, Chiang Mai 50100, Thailand.
- Center of Excellence in Agro Bio-Circular-Green Industry (Agro BCG), Chiang Mai University, Chiang Mai 50200, Thailand.
- Department of Chemistry, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
- School of Dentistry, Mae Fah Luang University, Chiang Rai 57100, Thailand.
ORCID-Profile: Pornchai Rachtanapun, Patnarin Worajittiphon, Pensak Jantrawut
Förderung
- National Research Council of Thailand
- Chiang Mai University
Zitieren
APA
O-Chongpian, P., Chaiwarit, T., Jantanasakulwong, K., Rachtanapun, P., Worajittiphon, P., Kantrong, N., & Jantrawut, P. (2023). Surface-Modified Carboxylated Cellulose Nanofiber Hydrogels for Prolonged Release of Polyhexamethylene Biguanide Hydrochloride (PHMB) for Antimicrobial Applications. Polymers, 15(17), 3572. https://doi.org/10.3390/polym15173572
Vancouver
O-Chongpian P, Chaiwarit T, Jantanasakulwong K, Rachtanapun P, Worajittiphon P, Kantrong N, et al. Surface-Modified Carboxylated Cellulose Nanofiber Hydrogels for Prolonged Release of Polyhexamethylene Biguanide Hydrochloride (PHMB) for Antimicrobial Applications. Polymers. 2023;15(17):3572. doi:10.3390/polym15173572
BibTeX
@article{OChongpian2023,
author = {O-Chongpian, Pichapar and Chaiwarit, Tanpong and Jantanasakulwong, Kittisak and Rachtanapun, Pornchai and Worajittiphon, Patnarin and Kantrong, Nutthapong and Jantrawut, Pensak},
title = {Surface-Modified Carboxylated Cellulose Nanofiber Hydrogels for Prolonged Release of Polyhexamethylene Biguanide Hydrochloride (PHMB) for Antimicrobial Applications},
journal = {Polymers},
year = {2023},
volume = {15},
number = {17},
pages = {3572},
doi = {10.3390/polym15173572}
}
EUVIMED